Results 1 to 10 of about 72,647 (276)

Tricuspid valve papillary fibroelastoma in an adult patient: a case report and review of literature [PDF]

Journal of Cardiothoracic Surgery
Background Tricuspid valve papillary fibroelastoma is a rare, benign primary cardiac tumor located on the tricuspid valve, with a potential risk of embolism.
Zhenchun Ji, Changhui Yu, Kadeerjiang Musha, Liangqiang Lin, Baihetiya Saimi, Abudusalamu Abudurexiti, Haoyue Huang, Zhenya Shen   +7 more
doaj   +2 more sources

The evolving role of multi-modality imaging in transcatheter tricuspid valve interventions

Frontiers in Cardiovascular Medicine, 2022
Tricuspid valve pathophysiology is not well-understood. Emergence of novel transcatheter tricuspid therapies has fueled the requirements for improved imaging visualization techniques and interventional imaging physician skillsets in guiding these complex
Livia Luciana Gheorghe, Romy Hegeman, Martijn Vrijkorte, Nina Wunderlich, Joao Cavalcante, Dee Dee Wang, Bushra Rana, Mani Vannan, Leo Timmers, Martin Swaans   +9 more
doaj   +2 more sources

Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement. [PDF]

Europace
Defaye P, Jacon P, Venier S.
europepmc   +3 more sources

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review [PDF]

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano, Sabrina Trippoli, Andrea Messori, Vincenzo Calderone, Eugenia Piragine   +4 more
doaj   +2 more sources

The long-term impact of the tricuspid valve intervention after Fontan completion. [PDF]

Egypt Heart J
Kulyabin Y, Soynov I, Lancaster T, Sood V, Romano J, Ohye R, Moon J.   +6 more
europepmc   +3 more sources

Tricuspid valve replacement provides better long-term survival and tricuspid valve function than repair in patients with systemic right ventricleCentral MessagePerspective

JTCVS Open, 2023
Objective: The purpose of this study is to compare the long-term outcomes of 2 different tricuspid surgeries including valvuloplasty and replacement for significant tricuspid regurgitation in patients with systemic right ventricle.
Akihisa Furuta, MD, PhD, Takeshi Shinkawa, MD, PhD, Satoshi Okugi, MD, Hisashi Yoshida, MD, Hiroshi Niinami, MD, PhD   +4 more
doaj   +1 more source

Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomalyCentral MessagePerspective

JTCVS Open, 2023
Objective: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients.
Rebekah Boyd, MD, David Kalfa, MD, PhD, Stephanie Nguyen, MD, Matan Setton, MD, Amee Shah, MD, John Karamichalis, MD, Matthew Lewis, MD, Noa Zemer Wassercug, MD, Marlon Rosenbaum, MD, Emile Bacha, MD   +9 more
doaj   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

Case Reports in Cardiology, 2022
Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang, Hui Xue, Lifu Miao, Xiujie Tang, Yanbin Shao   +4 more
doaj   +1 more source

Update on Transcatheter Tricuspid Valve Replacement Therapies

Frontiers in Cardiovascular Medicine, 2021
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg, Edwin Ho, Mei Chau, Azeem Latib   +3 more
doaj   +1 more source

Tricuspid valve endocarditis [PDF]

Annals of Cardiothoracic Surgery, 2019
Right-sided infective endocarditis (RSIE) encompasses 5–10% of all infective endocarditis (IE) cases. Among them, about 90% involve the tricuspid valve (TV) (1). Major risk factors for TV infective endocarditis (TVIE) are intravenous drug use, pacemaker (PM) leads and indwelling vascular accesses (1,2). Only between 5–16% of RSIE cases require surgical
Mateo, Marin-Cuartas, Martin, Misfeld, Michael A, Borger, Bettina, Pfannmüller   +3 more
openaire   +2 more sources